Skip to main content

Oncolytics Bio(ONC-T)
TSX

Today's Change
Real-Time Last Update

Stocks in play: Oncolytics Biotech Inc

Baystreet - Fri Mar 8, 8:40AM CST

Announced recent operational highlights and financial results for the fourth quarter and year ended December 31, 2023. Highlights include; Pelareorep advancing to a registration-enabling study in 2024 in pancreatic cancer and expands pancreatic potential with new GOBLET cohort in combination with mFOLFIRINOX; Impressive objective response rate in GOBLET study anal carcinoma cohort supports enrollment expansion;Expecting to report overall survival data from BRACELET-1 breast cancer study in 2024; Cash position of $34.9 million provides runway through critical milestones into 2025. Oncolytics Biotech Inc shares T.ONC are trading unchanged at $1.41.

Provided Content: Content provided by Baystreet. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe